Treatment with AAV9-shNinj1 significantly decreased collagen deposition, α smooth muscle actin (α-SMA) and fibronectin (FN) expression at day 28 after AKI, consequently rescued the worsen renal function (Figure 5A-F). This evidence concerns the gene ACTA1 and acute kidney injury.